Clinical Trial Update: Diuretic and Renal Effects of Vaprisol When Administered Along With Furosemide and Nesiritide Continuous Infusion [Phase 4]

View source ↗

Summary

Phase 4 study assessing the diuretic and renal effects of Vaprisol when given with furosemide and nesiritide continuous infusion has been withdrawn. The status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Vaprisol (Conivaptan)

Snippet

Sponsor: Albert Einstein Healthcare Network | Conditions: Heart Failure | Phase 4 | Status: WITHDRAWN